Seminars in Oncology
Volume 35, Issue 6 , Pages 582-589, December 2008

Ovarian Cancer in Older Women

  • William P. Tew

      Affiliations

    • Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
    • Corresponding Author InformationAddress correspondence to William P. Tew, MD, Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021
    • ,
  • Stuart M. Lichtman

      Affiliations

    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, Commack, NY

Advancing age is considered a risk factor for survival in ovarian cancer. Several groups reported at least a twofold increased risk of death in women older than 65 years of age. In this review, we will focus on several aspects of the management of ovarian cancer in the elderly, including the prognostic implications of advanced age, surgical considerations in the frail, chemotherapy options such as intraperitoneal (IP) treatment, and geriatric assessment in predicting toxicity.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(08)00190-5

doi:10.1053/j.seminoncol.2008.08.007

Seminars in Oncology
Volume 35, Issue 6 , Pages 582-589, December 2008

Article Tools